Glucose-Lowering Drugs and Risk of COPD Exacerbations in Adults with Type 2 Diabetes

被引：0
|
作者：
Ray, Avik
Paik, Julie M.
Feldman, William B.
Sreedhara, Sushama Kattinakere
Wexler, Deborah J.
Patorno, Elisabetta
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-796-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
796-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes
    Preiser, Jean-Charles
    Provenzano, Bruna
    Mongkolpun, Wasineeart
    Halenarova, Katarina
    Cnop, Miriam
    ANESTHESIOLOGY, 2020, 133 (02) : 430 - 438
  • [22] Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
    Holman, Rury R.
    Sourij, Harald
    Califf, Robert M.
    LANCET, 2014, 383 (9933): : 2008 - 2017
  • [23] Cardiovascular Outcomes Trials of Glucose-Lowering Drugs or Strategies in Type 2 Diabetes
    Gerstein, Hertzel C.
    Shah, Reema
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 97 - +
  • [24] Glucose-lowering effects of sulfasalazine in type 2 diabetes
    Haas, RM
    Li, P
    Chu, JW
    DIABETES CARE, 2005, 28 (09) : 2238 - 2239
  • [25] Cardiovascular Effects of Glucose-lowering Therapies for Type 2 Diabetes: New Drugs in Perspective
    Thompson, Peter L.
    Davis, Timothy M. E.
    CLINICAL THERAPEUTICS, 2017, 39 (05) : 1012 - 1025
  • [26] Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update
    Tomlinson, Brian
    Chan, Paul
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (04) : 175 - 179
  • [27] Exploring the impact of type 2 diabetes and glucose-lowering drugs on gut microbiome dynamics
    Hafiz Muhammad Adnan Tariq
    Nayyab Younas Khan
    Haseeb Manzoor
    Masood Ur Rehman Kayani
    Discover Medicine, 2 (1):
  • [28] The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese
    Hsieh, Ming-Chia
    Lee, Tzu-Chi
    Cheng, Shu-Min
    Tu, Shih-Te
    Yen, Ming-Hong
    Tseng, Chin-Hsiao
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [29] Newer second-line glucose-lowering drugs versus thiazolidinediones and cirrhosis risk in type 2 diabetes
    Yang, Jeff Y.
    Alexopoulos, Anastasia
    Moon, Andrew M.
    Kim, Hannah
    Pate, Virginia
    Barritt, A. Sidney
    Sturmer, Til
    Buse, John B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 606 - 606
  • [30] Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
    Patti, Angelo Maria
    Rizvi, Ali A.
    Giglio, Rosaria Vincenza
    Stoian, Anca Pantea
    Ligi, Daniela
    Mannello, Ferdinando
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
12345